Clinical Research Directory

Inclusion criteria: 1. Age greater than 18 years; 2. Meets the diagnostic criteria for sepsis according to the "Sepsis-3" ; 3. Patient or their legal representative consents to treatment and signs an informed consent form. Exclusion criteria: 1. Patients expected to die within 24 hours after enrollment; 2. Contraindications to low molecular weight heparin and scopolamine butylbromide drugs; 3. Patients with thrombotic diseases requiring treatment with low molecular weight heparin; 4. Patients with terminal-stage malignancies, severe immunodeficiency, immunosuppression, severe liver or kidney dysfunction (defined as liver or kidney SOFA score ≥ 3 points), etc.; 5. Pregnant and lactating women; 6. Patients participating in other clinical trials.